Iowa Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 13 (93% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 5,005
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 40.65%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 783
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 41.87%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 55.08% 53.90%
White, Hispanic/Latino Patients 15.16% 19.92%
Black/African American, Non-Hispanic/Latino Patients 11.27% 5.49%
Black/African American, Hispanic/Latino Patients 0.14% 0.13%
Asian Patients3 1.70% 1.28%
American Indian/Alaska Native Patients3 1.36% 0.89%
Native Hawaiian/Other Pacific Islander Patients3 0.56% 0.89%
Patients with More than one race3 2.74% 2.55%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 4.80% 7.66%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.06% 2.43%
Unreported/Refused to Report Race and Ethnicity 5.13% 4.85%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 604
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 70.19%
COVID-19 Immunization Series Completed 815
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 66.37%
COVID-19 Immunization Series Additional 41
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 24.39%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 28.48% 32.27% 75.61%
White, Hispanic/Latino Patients 26.16% 29.08% 7.32%
Black/African American, Non-Hispanic/Latino Patients 23.18% 14.11% 14.63%
Black/African American, Hispanic/Latino Patients 0.33% 0.25% 0.00%
Asian Patients3 5.46% 6.75% 2.44%
American Indian/Alaska Native Patients3 0.83% 3.80% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 4.30% 4.79% 0.00%
Patients with More than one race3 1.32% 0.49% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 5.46% 4.42% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.49% 1.47% 0.00%
Unreported/Refused to Report Race and Ethnicity 2.98% 2.58% 0.00%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 23.08%
1 to 24 Hours 30.77%
More Than 24 Hours 46.15%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 7.69%
Staffing to administer the vaccine 0.00%
Vaccine confidence 46.15%
Vaccine storage capacity 0.00%
Vaccine supply 7.69%
Other 0.00%
None 46.15%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 100.00%
Average Percent of Health Center Visits Conducted Virtually 10.38%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 15.38%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 61.54%
None 38.46%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 7.69%
Patient awareness/education 7.69%
Staffing capacity 15.38%
Therapy administration/onsite logistics 15.38%
Other 15.38%
None 61.54%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021